Swedish Orphan Biovitrum AB (publ)
BIOVF News Today: Stay Updated with the Latest Swedish Orphan Biovitrum AB (publ) News in Real Time
Find BIOVF news now at Meyka AI. Stay informed with the latest Swedish Orphan Biovitrum AB (publ) stocks updates, including price news, market analysis, and expert insights.
Vol 15,112 hits ORPH.IR Open Orphan (EURONEXT) 27 Feb 2026: watch EUR 0.14 support
Pre-market volume spike in ORPH.IR stock to 15,112, trading at EUR 0.14 on EURONEXT; quick analysis and price outlook
Barclays keeps Overweight on Sandvik AB (publ) SDVKY; PT SEK 400 Feb 2026
SDVKY analyst rating: Barclays maintains Overweight and raises PT to SEK 400 on Feb 25, 2026
Citi Maintains Neutral on HNNMY (H & M Hennes & Mauritz AB) Feb 25, 2026
Citi maintains Neutral on HNNMY analyst rating, raises price target to SEK 174 on Feb 25, 2026
Morgan Stanley Maintains Underweight on Boliden AB (publ) BDNNY Feb 25 2026
Morgan Stanley kept Underweight and raised the price target for Boliden; BDNNY analyst rating, implications, and Meyka Grade B+
Barclays Maintains Overweight on BIOVF Swedish Orphan Biovitrum Feb 2026
Barclays maintained Overweight on BIOVF with a higher SEK 470 price target in Feb 2026; BIOVF analyst rating coverage explained
ORPH.IR volume spike Open Orphan (EURONEXT) pre-market 25 Feb: liquidity rising
Pre-market volume spike in ORPH.IR stock on 25 Feb 2026; 15,112.00 shares trade prompts liquidity and valuation review
Market closed 24 Feb 2026: Recomm Co. (3323.T) JPY 95.00 down 5.26%, watch leverage
3323.T stock closed JPY 95.00 on 24 Feb 2026. We review valuation, technicals and Meyka AI forecasts for downside risk and short-term targets.
ALFVY Alfa Laval AB (publ): Morgan Stanley Maintains Underweight Feb 2026
ALFVY analyst rating: Morgan Stanley maintains Underweight and raises PT to SEK 466 on Feb 23, 2026
Morgan Stanley maintains Underweight on SAABF Saab AB (publ) Feb 23 2026
SAABF analyst rating: Morgan Stanley kept Underweight and raised target to SEK 540 on Feb 23, 2026